High serum bone-specific alkaline phosphatase level after bortezomib-combined therapy in refractory multiple myeloma: possible role of bortezomib on osteoblast differentiation

Leukemia. 2005 Jun;19(6):1102-3. doi: 10.1038/sj.leu.2403758.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Alkaline Phosphatase / blood*
  • Antineoplastic Agents / administration & dosage*
  • Boronic Acids / administration & dosage*
  • Bortezomib
  • Cell Differentiation / drug effects
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / complications
  • Multiple Myeloma / drug therapy*
  • Osteoblasts / cytology
  • Osteoblasts / drug effects*
  • Osteoblasts / enzymology
  • Pyrazines / administration & dosage*
  • Spinal Fractures / complications*

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Pyrazines
  • Bortezomib
  • Alkaline Phosphatase